Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference
(AZTR) BRANFORD, Conn., Sept. 4, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that Cofounder and Chief Operating Officer, Travis Whitfill PhD MPH, will...